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INTRODUCTION
Despite significant advancements in cardiac care, cardio-
vascular diseases (CVDs) are the main cause of mortality in 
Poland. Thus, they should be a priority in the national health 
policy. In addition, further optimisation of medical care re-
quires maintenance of an effective, integrated, and networked 
structure of the treatment of CVDs. In Poland, treatment of 
coronary artery disease, including acute coronary syndrome 
(ACS), is currently provided complimentarily by a network of 
high- and low-volume percutaneous coronary intervention 
(PCI) centres. Importantly, the network has been organised 
and developed by Polish cardiologists for almost 20 years. Dur-
ing that period, multiple strategies have been introduced to 
improve the safety and efficacy of national care for patients 
with ACS. These have included a reduction of the time from 
first medical contact to reperfusion through an increase in the 
availability of primary-PCI centres, direct transfer, bypassing 
non-PCI-capable hospitals or emergency departments, and 
early cath lab activation after electrocardiogram teletransmis-
sion from the field [1–5]. Despite this, approximately 50% 
of patients with ST-segment elevation myocardial infarction 
(STEMI) are still not transferred directly to the appropriate 
facility and may experience an unnecessary delay to reperfu-
sion [3, 4]. Thus, regional and countrywide systems of care 
face an ongoing challenge of determining the best policies 
for geographical distribution of cath labs and time frames of 
transferring the patients from referring centres to primary-PCI 
hospitals. Data on the current activity and geographical distri-
bution of cath labs may be helpful to refine the network. Thus, 
we sought to evaluate the current number, performance, and 
localisation of PCI facilities in Poland, based on data from the 
Polish National PCI Registry (ORPKI).
METHODS
The ORPKI Registry is operated by the Jagiellonian University 
Medical College in Krakow, Poland (https://www.orpki.cm-uj.
krakow.pl/) and is endorsed by the Polish Association of Car-
diovascular Interventions of the Polish Cardiac Society (AISN 
PTK) [6]. The registration in the ORPKI database is voluntary; 
however, as much as 98% of all catheterisation laboratories in 
Poland have joined the registry. For this study, complete data 
for 2016 collected from 157 cath labs were extracted. The 
centres were divided into high-volume (≥ 400 PCIs/year) and 
low-volume (< 400 PCIs/year), depending on the total number 
of all PCIs performed in a particular cath lab in 2016. A cut-off 
value of 400 PCIs/year was selected, as recommended by the 
European Society of Cardiology (ESC) guidelines on myocardial 
revascularisation [6]. In addition, data from the highest-volume 
centres, according to a cut-off value of 1000 PCIs/year, were 
assessed. Subsequently, data concerning numbers of PCIs were 
stratified by the initial diagnosis.
RESULTS AND DISCUSSION
In 2016, 115,790 PCIs were performed in 157 cath labs 
in Poland. On average, each invasive cardiology facility 
provided care for a mean of 239,000 inhabitants. A total 
of 26 centres performed < 400 PCIs/year (5604 PCIs, 22% 
STEMI, 22% non-STEMI [NSTEMI], 27% unstable angina, 27% 
stable angina), and 131 centres performed ≥ 400 PCIs/year 
(110,186 PCIs, 19% STEMI, 17% NSTEMI, 31% unstable 
angina, 32% stable angina). 4.8% of all PCI procedures were 
performed in low-volume centres, which comprised 17% 
of all PCI centres. Notably, 72.5% of PCIs in low-volume 
centres were performed in patients with ACS. The distribu-
tion of cath labs depending on the number of PCIs/year 
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is presented in Figure 1A, B. A total of 32 centres per-
formed > 1000 PCIs/year (42,533 PCIs, 15% STEMI, 14% 
NSTEMI, 34% unstable angina, 36% stable angina) and 
125 centres performed < 1000 PCIs/year (73,257 PCIs, 
22% STEMI, 19% NSTEMI, 30% unstable angina, 29% stable 
angina; Fig. 1C, D).
The current report underlines the importance of low-vol-
ume PCI centres operating on a 24/7 basis in providing cardio-
vascular care for patients in Poland. Despite the fact that only 
4.8% of all PCIs were performed in low-volume PCI centres, 
these centres seem to be crucial in providing care to patients 
presenting with ACS. The distribution of complementary high- 
and low-volume centres corresponding to population density 
seems to be optimal for the covered regions. In 2016, those 
160 (157 reporting centres) cath labs operating 24/7 provided 
cardiac care for an average of 239,000 inhabitants. These num-
bers are consistent with the requirements of AISN PTK and ESC 
guidelines [7–9]. To build an effective system of STEMI care, 
partnerships between STEMI-referral hospitals, primary-PCI 
hospitals, and emergency system teams are critical (a so-called 
“hub-and-spoke” system) [10]. Networks for STEMI and ACS 
treatment allow a reduction of the time from the onset of 
symptoms to reperfusion [5]. Importantly, further reduction 
of delay to reperfusion is crucial because the prolongation 
of time to reperfusion may adversely affect outcomes [5]. 
Thus, the main rationale for the support of low-volume 
PCI centres is their geographical availability. The reduction 
in time from the first medical contact to balloon inflation 
depends on the pattern in which the patient is referred to 
the cath lab [5]. In addition, close cooperation between 
primary-PCI facilities, non-PCI-capable hospitals, and 
emergency medical services may allow optimisation of 
pre-hospital treatment of ACS patients [11]. The total num-
ber of PCI procedures in each centre is also dependent on 
the type of the contract with the National Health Service. 
Low-volume centres have a limited financial contract for 
elective procedures and have been able so far to perform 
urgent PCIs without limits.
Figure 1. Map of Poland with the geographical distribution of cath labs depending on the number of percutaneous coronary 
interventions (PCIs) performed in 2016; A. Centres with ≥ 400 PCIs/year; B. Additionally added centres with < 400 PCIs/year;  
C. Centres with ≥ 1000 PCIs/year; D. Additionally added centres with < 1000 PCIs/year. Marked hypothetical areas providing 
possible transfer and PCI for patients with acute myocardial infarction within 90 min from the first medical contact
A B
C D
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Despite differences in the number of procedures 
performed in PCI centres, from the geographical perspec-
tive, low-volume facilities are equally as important as the 
high-volume ones because they especially serve patients 
presenting with ACS. Distribution of high- and low-volume 
centres seems optimal. However, in the perspective of an 
ageing population, further efforts are needed to enhance 
cardiovascular care networks.
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